Cargando…

The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability

The relationship of relapses to long-term disability in multiple sclerosis is uncertain. Relapse reduction is a common therapeutic target but clinical trials have shown dissociation between relapse suppression and disability accumulation. We investigated relationships between relapses and disability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scalfari, Antonio, Neuhaus, Anneke, Degenhardt, Alexandra, Rice, George P., Muraro, Paolo A., Daumer, Martin, Ebers, George C.
Formato:	Texto
Lenguaje:	English
Publicado:	Oxford University Press 2010
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892939/ https://www.ncbi.nlm.nih.gov/pubmed/20534650 http://dx.doi.org/10.1093/brain/awq118

Ejemplares similares

A Web-based tool for personalized prediction of long-term disease course in patients with multiple sclerosis
por: Galea, I, et al.
Publicado: (2013)

Reducing the probability of false positive research findings by pre-publication validation – Experience with a large multiple sclerosis database
por: Daumer, Martin, et al.
Publicado: (2008)

Validating Predictors of Disease Progression in a Large Cohort of Primary-Progressive Multiple Sclerosis Based on a Systematic Literature Review
por: Stellmann, Jan-Patrick, et al.
Publicado: (2014)

A novel prognostic score to assess the risk of progression in relapsing−remitting multiple sclerosis patients
por: Pisani, Anna Isabella, et al.
Publicado: (2021)

Early non-disabling relapses are important predictors of disability accumulation in people with relapsing-remitting multiple sclerosis
por: Daruwalla, Cyrus, et al.
Publicado: (2023)

Multiple sclerosis: major histocompatibility complexity and antigen presentation
por: Ramagopalan, Sreeram V, et al.
Publicado: (2009)

MS can be considered a primary progressive disease in all cases, but some patients have superimposed relapses – Yes
por: Scalfari, Antonio
Publicado: (2021)

Prognostic Risk Estimates of Patients with Multiple Sclerosis and Their Physicians: Comparison to an Online Analytical Risk Counseling Tool
por: Heesen, Christoph, et al.
Publicado: (2013)

Assessing disability and relapses in multiple sclerosis on tele-neurology
por: Moccia, Marcello, et al.
Publicado: (2020)

Siponimod: Disentangling disability and relapses in secondary progressive multiple sclerosis
por: Cree, Bruce AC, et al.
Publicado: (2020)

The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis
por: Hadgkiss, Emily J, et al.
Publicado: (2015)

Prognosis of the individual course of disease - steps in developing a decision support tool for Multiple Sclerosis
por: Daumer, M, et al.
Publicado: (2007)

The natural history of multiple sclerosis
por: Confavreux, Christian, et al.
Publicado: (2006)

Ecological Validity of Walking Capacity Tests in Multiple Sclerosis
por: Stellmann, J. P., et al.
Publicado: (2015)

White matter lesion location correlates with disability in relapsing multiple sclerosis
por: Gaetano, Laura, et al.
Publicado: (2020)

Relapse recovery in multiple sclerosis: Effect of treatment and contribution to long-term disability
por: Sotiropoulos, Marinos G, et al.
Publicado: (2021)

Associations among stressors across the lifespan, disability, and relapses in adults with multiple sclerosis
por: Polick, Carri S., et al.
Publicado: (2023)

Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability
por: Jelinek, George A., et al.
Publicado: (2015)

Protein-Protein Interaction Analysis Highlights Additional Loci of Interest for Multiple Sclerosis
por: Ragnedda, Giammario, et al.
Publicado: (2012)

Worse Physical Disability Is Associated With the Expression of PD-1 on Inflammatory T-Cells in Multiple Sclerosis Patients With Older Appearing Brains
por: Jacobs, Sophie A. H., et al.
Publicado: (2022)

The Epidemiology of Multiple Sclerosis in Scotland: Inferences from Hospital Admissions
por: Handel, Adam E., et al.
Publicado: (2011)

Impact of Natalizumab on Ambulatory Improvement in Secondary Progressive and Disabled Relapsing-Remitting Multiple Sclerosis
por: Cadavid, Diego, et al.
Publicado: (2013)

Cognitive Impairment in Relapsing-Remitting Multiple Sclerosis Patients with Very Mild Clinical Disability
por: Migliore, S., et al.
Publicado: (2017)

Retinal layer thinning is reflecting disability progression independent of relapse activity in multiple sclerosis
por: Bsteh, Gabriel, et al.
Publicado: (2020)

Natural History and Prognostic Factors at First Relapse in Multiple Myeloma
por: Wang, Chen, et al.
Publicado: (2020)

Congenital Abnormalities and Multiple Sclerosis
por: Ramagopalan, Sreeram V, et al.
Publicado: (2010)

Retinal measurements predict 10‐year disability in multiple sclerosis
por: Rothman, Alissa, et al.
Publicado: (2019)

Association between Walking Speed and Age in Healthy, Free-Living Individuals Using Mobile Accelerometry—A Cross-Sectional Study
por: Schimpl, Michaela, et al.
Publicado: (2011)

The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing–remitting multiple sclerosis
por: Caligiuri, Maria Eugenia, et al.
Publicado: (2014)

Age of Onset in Concordant Twins and Other Relative Pairs With Multiple Sclerosis
por: Sadovnick, A. Dessa, et al.
Publicado: (2009)

Geographical variation in Plasmodium vivax relapse
por: Battle, Katherine E, et al.
Publicado: (2014)

The Natural History of Alcoholism
por: Vaillant, George E., et al.
Publicado: (1996)

Placebo Cohorts in Phase-3 MS Treatment Trials – Predictors for On-Trial Disease Activity 1990-2010 Based on a Meta-Analysis and Individual Case Data
por: Stellmann, Jan-Patrick, et al.
Publicado: (2012)

Outcome Measures in Relapsing-Remitting Multiple Sclerosis: Capturing Disability and Disease Progression in Clinical Trials
por: Lavery, Amy M., et al.
Publicado: (2014)

Intrinsic Functional Plasticity of the Thalamocortical System in Minimally Disabled Patients with Relapsing-Remitting Multiple Sclerosis
por: Zhou, Fuqing, et al.
Publicado: (2016)

Oxidative Stress Related to Iron Metabolism in Relapsing Remitting Multiple Sclerosis Patients With Low Disability
por: Siotto, Mariacristina, et al.
Publicado: (2019)

Functional and structural connectivity substrates of cognitive performance in relapsing remitting multiple sclerosis with mild disability
por: Has Silemek, Arzu Ceylan, et al.
Publicado: (2020)

Assessment of Disability Progression Independent of Relapse and Brain MRI Activity in Patients with Multiple Sclerosis in Poland
por: Kapica-Topczewska, Katarzyna, et al.
Publicado: (2021)

Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis
por: Cree, Bruce AC, et al.
Publicado: (2021)

Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies
por: Iaffaldano, Pietro, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ftsn3gg883faifmtfrh0f0bq92